CONTROL OF DISEASE

Section 12.1 Reserved

Section 12.2 - Precautions to be observed for the prevention of purulent conjunctivitis of the newborn

12.2 Precautions to be observed for the prevention of purulent conjunctivitis of the newborn. It shall be the duty of the attending physician, licensed midwife, licensed nurse or other authorized provider in attendance at a delivery to place into the eyes of the infant, on delivery, an agent effective for preventing purulent conjunctivitis of the newborn, such as tetracycline or erythromycin eye preparation or a one percent solution of nitrate of silver.
 

Effective Date: 
Wednesday, July 19, 2000
Doc Status: 
Complete

Section 12.3 - Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency

12.3 Precautions to be observed for the prevention of hemorrhagic diseases and coagulation disorders of the newborn and infants related to vitamin K deficiency. It shall be the duty of the attending physician, licensed midwife, registered professional nurse or other licensed medical professional attending the newborn to assure administration of a single intramuscular dose of 0.5 - 1.0 mg. of vitamin K1 oxide (phytonadione) within six hours of birth in accordance with current standards of medical care.

Effective Date: 
Tuesday, June 10, 2014
Doc Status: 
Complete